ASB1 differential methylation in ischaemic cardiomyopathy. Relationship with left ventricular performance in end stage heart failure patients
Authors:
Ana Ortega,
Estefanía Tarazón,
Carolina Gil-Cayuela,
Luis Martínez-Dolz,
Francisca Lago,
José Ramón González-Juanatey,
Juan Sandoval,
Manuel Portolés,
Esther Roselló-Lletí,
Miguel Rivera
Abstract:
Aims: Ischaemic cardiomyopathy (ICM) leads to impaired contraction and ventricular dysfunction causing high rates of morbidity and mortality. Epigenomics allows the identification of epigenetic signatures in human diseases. We analyse the differential epigenetic patterns of ASB gene family in ICM patients and relate these alterations to their haemodynamic and functional status. Methods and Results…
▽ More
Aims: Ischaemic cardiomyopathy (ICM) leads to impaired contraction and ventricular dysfunction causing high rates of morbidity and mortality. Epigenomics allows the identification of epigenetic signatures in human diseases. We analyse the differential epigenetic patterns of ASB gene family in ICM patients and relate these alterations to their haemodynamic and functional status. Methods and Results: Epigenomic analysis was carried out using 16 left ventricular (LV) tissue samples, 8 from ICM patients undergoing heart transplantation and 8 from control (CNT) subjects without cardiac disease. We increased the sample size up to 13 ICM and 10 CNT for RNA-sequencing and to 14 ICM for pyrosequencing analyses. We found a hypermethylated profile (cg11189868) in the ASB1 gene that showed a differential methylation of 0.26 beta difference, P < 0.05. This result was validated by pyrosequencing technique (0.23 beta difference, P < 0.05). Notably, the methylation pattern was strongly related to LV ejection fraction (r = -0.849, P = 0.008) stroke volume (r = -0.929, P = 0.001) and end-systolic and diastolic LV diameters (r = -0.743, P = 0.035 for both). ASB1 showed a down regulation in mRNA levels (-1.2 fold, P < 0.05). Conclusion: Our findings link a specific ASB1 methylation pattern to LV structure and performance in end-stage ICM, opening new therapeutic opportunities and providing new insights regarding which is the functionally relevant genome in the ischemic failing myocardium. Keywords: ischaemic cardiomyopathy; epigenomics; heart failure; left ventricular dysfunction; stroke volume; ASB1.
△ Less
Submitted 4 April, 2017;
originally announced April 2017.
Diffusion MRI microstructure models with in vivo human brain Connectom data: results from a multi-group comparison
Authors:
Uran Ferizi,
Benoit Scherrer,
Torben Schneider,
Mohammad Alipoor,
Odin Eufracio,
Rutger H. J. Fick,
Rachid Deriche,
Markus Nilsson,
Ana K. Loya-Olivas,
Mariano Rivera,
Dirk H. J. Poot,
Alonso Ramirez-Manzanares,
Jose L. Marroquin,
Ariel Rokem,
Christian Pötter,
Robert F. Dougherty,
Ken Sakaie,
Claudia Wheeler-Kingshott,
Simon K. Warfield,
Thomas Witzel,
Lawrence L. Wald,
José G. Raya,
Daniel C. Alexander
Abstract:
A large number of mathematical models have been proposed to describe the measured signal in diffusion-weighted (DW) magnetic resonance imaging (MRI) and infer properties about the white matter microstructure. However, a head-to-head comparison of DW-MRI models is critically missing in the field. To address this deficiency, we organized the "White Matter Modeling Challenge" during the International…
▽ More
A large number of mathematical models have been proposed to describe the measured signal in diffusion-weighted (DW) magnetic resonance imaging (MRI) and infer properties about the white matter microstructure. However, a head-to-head comparison of DW-MRI models is critically missing in the field. To address this deficiency, we organized the "White Matter Modeling Challenge" during the International Symposium on Biomedical Imaging (ISBI) 2015 conference. This competition aimed at identifying the DW-MRI models that best predict unseen DW data. in vivo DW-MRI data was acquired on the Connectom scanner at the A.A.Martinos Center (Massachusetts General Hospital) using gradients strength of up to 300 mT/m and a broad set of diffusion times. We focused on assessing the DW signal prediction in two regions: the genu in the corpus callosum, where the fibres are relatively straight and parallel, and the fornix, where the configuration of fibres is more complex. The challenge participants had access to three-quarters of the whole dataset, and their models were ranked on their ability to predict the remaining unseen quarter of data. In this paper we provide both an overview and a more in-depth description of each evaluated model, report the challenge results, and infer trends about the model characteristics that were associated with high model ranking. This work provides a much needed benchmark for DW-MRI models. The acquired data and model details for signal prediction evaluation are provided online to encourage a larger scale assessment of diffusion models in the future.
△ Less
Submitted 9 November, 2016; v1 submitted 25 April, 2016;
originally announced April 2016.
